Objective To discuss the val ue of simvastatin plus fenofibrate for the treatment of mixed hyperlipemia.
目的探讨辛伐他汀联合非诺贝特治疗混合性高脂血症的价值。
Methods All the 126 patients with mixed hyperlipemia were divided into three groups (42 ones per group).
方法将126例混合性高脂血症患者分为三组，每组42例。
Results Among the different hyperlipemia, the sickness rate of fatty liver with hypertriglyceridemia or mixed hyperlipemia is higher 85.
结果不同类型高脂血症中，以高甘油三酯血症及混合型高脂血症者的脂肪肝患病率较高。
应用推荐